panitumumab
Amgen,Takeda
['colorectal', 'triplet', 'triplete', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rectal']
triplete trial showing folfoxiri egfr inhibitor is no better than doublet chemo egfr inhibitor in #colorectalcancer.
#asco22 #crcsm 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own